🇺🇸 FDA
Patent

US 11857647

Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof

granted A61KA61K31/66A61K47/12

Quick answer

US patent 11857647 (Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof) held by Jubilant Draximage Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jubilant Draximage Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/66, A61K47/12, A61K51/025, A61K51/0478